vimarsana.com

Latest Breaking News On - Astrazeneca pharma india ltd - Page 1 : vimarsana.com

DCGI Orders Withdrawal of AstraZeneca s Cancer Drug Olaparib for Some Treatments

The Drug Controller General of India (DCGI) has asked drug regulators in all states and Union territories to withdraw AstraZeneca s anti-cancer drug Olaparib tablets for treatment in patients who have received three or more prior lines of chemotherapy.

Fighting rare diseases through innovation - The Hindu BusinessLine

Fighting rare diseases through innovation - The Hindu BusinessLine
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Bengaluru water crisis: Firms gulp more but also pledge to reduce usage

Water consumption in large listed companies registered in Bengaluru rose in fiscal year 2022-23, but some also showed commitment to reduce their water footprint and recycle more.

AstraZeneca Pharma India appoints Vinay Sharma as business unit head

AstraZeneca Pharma India appoints Vinay Sharma as business unit head
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

AstraZeneca Pharma India, Mankind Pharma ink pact to distribute asthma medicine

AstraZeneca Pharma India Ltd and Mankind Pharma Ltd on Monday said they have entered into an agreement for exclusive distribution of the Symbicort brand, an asthma medicine, in India. Symbicort is owned by AstraZeneca, which will retain the intellectual property rights and will continue to be the

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.